home / stock / bthe / bthe quote
Last: | $0.01 |
---|---|
Change Percent: | 0.0% |
Open: | $0.00915 |
Close: | $0.01 |
High: | $0.0119 |
Low: | $0.0091 |
Volume: | 105,242 |
Last Trade Date Time: | 11/12/2021 04:54:33 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.01 | $0.00915 | $0.01 | $0.0119 | $0.0091 | 105,242 | 11-12-2021 |
$0.01 | $0.011 | $0.01 | $0.011 | $0.0096 | 206,102 | 11-11-2021 |
$0.0117 | $0.0131 | $0.0117 | $0.0131 | $0.0116 | 212,435 | 11-10-2021 |
$0.013 | $0.013 | $0.013 | $0.013 | $0.013 | 11,366 | 11-09-2021 |
$0.0124 | $0.0195 | $0.0124 | $0.0195 | $0.0124 | 22,301 | 11-08-2021 |
$0.0119 | $0.0274 | $0.0119 | $0.0274 | $0.0119 | 510 | 11-05-2021 |
$0.0153 | $0.01525 | $0.0153 | $0.0153 | $0.0153 | 102 | 11-04-2021 |
$0.016 | $0.01545 | $0.016 | $0.016 | $0.0117 | 47,750 | 11-03-2021 |
$0.0168 | $0.0171 | $0.0168 | $0.0171 | $0.0168 | 5,100 | 11-01-2021 |
$0.017 | $0.014155 | $0.017 | $0.017 | $0.0142 | 252 | 10-29-2021 |
$0.0104 | $0.0104 | $0.0104 | $0.0104 | $0.0104 | 507 | 10-28-2021 |
$0.015 | $0.016 | $0.015 | $0.0161 | $0.0113 | 93,154 | 10-27-2021 |
$0.0167 | $0.01405 | $0.0167 | $0.0167 | $0.0113 | 10,300 | 10-26-2021 |
$0.0169 | $0.0169 | $0.0169 | $0.0169 | $0.0169 | 1,125 | 10-25-2021 |
$0.014 | $0.01405 | $0.014 | $0.0141 | $0.0111 | 11,647 | 10-21-2021 |
$0.0111 | $0.0138 | $0.0111 | $0.017 | $0.011 | 58,006 | 10-20-2021 |
$0.0175 | $0.0185 | $0.0175 | $0.0196 | $0.012 | 88,386 | 10-19-2021 |
$0.012 | $0.0178 | $0.012 | $0.0178 | $0.012 | 2,253 | 10-18-2021 |
$0.0195 | $0.0121 | $0.0195 | $0.0195 | $0.0121 | 33,754 | 10-15-2021 |
$0.0174 | $0.0169 | $0.0174 | $0.0174 | $0.016 | 30,112 | 10-13-2021 |
News, Short Squeeze, Breakout and More Instantly...
Boston Therapeutics Inc Company Name:
BTHE Stock Symbol:
OTCMKTS Market:
Boston Therapeutics Inc Website:
LAWRENCE, Mass., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Boston Therapeutics (OTCQB:BTHE) is again pleased to announce full enrollment of the BTI320 Ph 2 double-blind, placebo-controlled, multicenter trial. With the recent inclusion of Miami Dade Medical Research Institute in June and IOWA Diabet...
LAWRENCE, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Boston Therapeutics Inc. (the “ Company ” or “ BTI ”) (OTCQB:BTHE), an innovator in the design, development and commercialization of novel therapeutics as an adjunct therapy for diabetes, launches the initial sal...